Scientists from Zhejiang University have developed a novel delivery vehicle for CRISPR-Cas9 that is more effective than lipid nanoparticles (LNPs) in treating lung cancer. Rapid liquid nitrogen ...
1d
Simple 'cocktail' of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
Lipid nanoparticles (LNPs) act as carriers for mRNA and CRISPR payloads across a wide range of therapeutic applications, from cancer to inflammatory and genetic diseases. The same delivery system used ...
A recent study utilizing cryo-EM advances our understanding of how bacterial immune systems function and reveals new aspects ...
Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
UC and Broad have been involved in two interferences at the patent office. Interference No. 106,115 was the second interference between UC and Broad over patent rights to CRISPR-Cas9 technology in ...
Organizaciones instan a participar en consulta pública sobre nuevas técnicas genéticas y trigo editado Warnings are issued regarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results